Disruption to HIV treatment in Africa during COVID-19 pandemic could double HIV deaths, modelling studies warn
Stopping cotrimoxazole during antiretroviral therapy raises risk of bacterial illness, malaria, Ugandan trial shows
Protease inhibitor therapy doesn't reduce the risk of malaria for HIV-positive pregnant women
Lopinavir/ritonavir equivalent to nevirapine in Ugandan children
Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation
Preventing malaria and diarrhoea delays need for antiretroviral therapy
HIV and TB in Practice for nurses: cotrimoxazole prophylaxis
Lopinavir/ritonavir cuts malaria risk in children with HIV
